Extensive stage SCLC (Es-SCLC) | ||
Extensive stage SCLC (Es-SCLC) - maintenance (M) | Extensive stage SCLC (Es-SCLC) - 1st Line (L1) | |
anti-PD-(L)1 | ||
atezolizumab based treatment | ||
atezolizumab plus SoC | IMpower-133 | |
durvalumab based treatment | ||
durvalumab plus etoposide and platin | CASPIAN ... | |
nivolumab based treatment | ||
nivolumab alone | CheckMate 451 ... | |
pembrolizumab based treatment | ||
pembrolizumab plus SoC | KEYNOTE-604 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -